NEJM Reports on 2 New Drugs for Hepatitis C

Last week’s NEJM delivered an intriguing, imperfect article on a new approach to treating hepatitis C (HCV). The paper’s careful title, Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1, seems right. The analysis, with 17 authors listed, traces the response of 21 people with hepatitis C (HCV) who got two new anti-viral agents, with or […]

Posted in Academic Medicine, clinical trials, Infectious DiseaseTagged , , , , , , , , , 1 Comment on NEJM Reports on 2 New Drugs for Hepatitis C